Hudson Bay Capital Management LP Cellectis S.A. Transaction History

Hudson Bay Capital Management LP

$18.6 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.29 - $4.08 $459,071 - $817,909	-200,468 Reduced 72.9%	74,532 $171,000
Q2 2022 Aug 12, 2022	BUY	$2.39 - $4.93 $151,765 - $313,055	63,500 Added 30.02%	275,000 $778,000
Q1 2022 May 16, 2022	BUY	$3.45 - $8.77 $332,925 - $846,305	96,500 Added 83.91%	211,500 $960,000
Q4 2021 Feb 14, 2022	BUY	$8.01 - $12.84 $921,150 - $1.48 Million	115,000 New	115,000 $934,000
Q4 2020 Feb 12, 2021	SELL	$15.87 - $31.64 $1.05 Million - $2.08 Million	-65,855 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$15.7 - $20.84 $1.48 Million - $1.96 Million	-94,145 Reduced 58.84%	65,855 $1.22 Million
Q2 2020 Aug 12, 2020	SELL	$8.21 - $21.02 $205,250 - $525,500	-25,000 Reduced 13.51%	160,000 $2.85 Million
Q1 2020 May 14, 2020	BUY	$7.81 - $18.82 $429,550 - $1.04 Million	55,000 Added 42.31%	185,000 $1.7 Million
Q4 2019 Feb 12, 2020	SELL	$9.73 - $19.31 $389,200 - $772,400	-40,000 Reduced 23.53%	130,000 $2.23 Million
Q3 2019 Nov 13, 2019	BUY	$10.15 - $16.89 $862,750 - $1.44 Million	85,000 Added 100.0%	170,000 $1.77 Million
Q2 2019 Aug 14, 2019	SELL	$14.6 - $20.6 $146,000 - $206,000	-10,000 Reduced 10.53%	85,000 $1.33 Million
Q1 2019 May 15, 2019	BUY	$15.53 - $19.75 $77,650 - $98,750	5,000 Added 5.56%	95,000 $1.74 Million
Q4 2018 Feb 13, 2019	BUY	$15.58 - $28.41 $817,950 - $1.49 Million	52,500 Added 140.0%	90,000 $1.5 Million
Q3 2018 Nov 14, 2018	BUY	$25.99 - $30.6 $194,925 - $229,500	7,500 Added 25.0%	37,500 $1.06 Million
Q2 2018 Aug 13, 2018	BUY	$27.78 - $38.53 $833,400 - $1.16 Million	30,000 New	30,000 $849,000
Q1 2018 May 14, 2018	SELL	$27.78 - $35.19 $1.11 Million - $1.41 Million	-40,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$23.33 - $35.01 $933,199 - $1.4 Million	40,000	40,000 $1.17 Million

Others Institutions Holding CLLS

# of Institutions

Shares Held

11.2M

Call Options Held

2.8K

Put Options Held

17.9K

Long Focus Capital Management, LLC San Juan, PR

4.62M
Shares

$9.33 Million
0.35% of portfolio
Capital International Investors Los Angeles, CA

1.85M
Shares

$3.73 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.44M
Shares

$2.91 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

1.44M
Shares

$2.91 Million
0.0% of portfolio
Baillie Gifford & CO

708K
Shares

$1.43 Million
0.0% of portfolio

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $91.9M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account